Bill > HB955

This bill legalizes the use of psilocybin, a naturally occurring psychedelic compound, for the treatment of post-traumatic stress disorder (PTSD), anxiety, depressive, and substance use disorders in Montana. It establishes a regulatory framework to license and oversee therapeutic psilocybin treatment centers, clinicians, facilitators, and technicians. The bill sets requirements for patient certification, preparation and integration sessions, and supervised administration of psilocybin. It also provides legal protections for certified patients and licensed individuals, while prohibiting certain activities like operating a vehicle under the influence. The bill amends existing drug laws to exempt psilocybin use under this new regulatory system, and it creates a special revenue account to fund the administration of the program, which is set to terminate on June 30, 2027.